Avoro Capital Advisors LLC 4
4 · IMMUNOMEDICS INC · Filed Mar 20, 2020
Insider Transaction Report
Form 4
IMMUNOMEDICS INCIMMU
Aghazadeh Behzad
Director10% OwnerOther
Transactions
- Award
Common Stock, $0.01 par value per share
2020-03-20+100,000→ 100,000 total
Holdings
- 24,500,000(indirect: See footnote)
Common Stock, $0.01 par value per share
- 13,516
Common Stock, $0.01 par value per share
Footnotes (3)
- [F1]Dr. Aghazadeh was granted restricted stock units pursuant to the Issuer's 2014 Long-Term Incentive Plan. 1/3 of the restricted stock units vest on each of the first, second, and third anniversary of the date of grant, subject to Dr. Aghazadeh's continued service as the Company's Executive Chairman.
- [F2]Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock..
- [F3]Dr. Aghazadeh serves as the portfolio manager and controlling person of Avoro Capital Advisors LLC (formerly venBio Select Advisor LLC), a Delaware limited liability company (the "Investment Manager"). The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein. The securities reported herein are held on behalf of accounts managed by the Investment Manager.